PTCE Pharmacy Connect | Pharmacy Times

Optimizing Safety & Efficacy of BTK Inhibitors | PTCE Pharmacy Connect

Foundations of Evidence for the Use of BTK Inhibitors in B-Cell Malignancies and Management Strategies for Cardiac and Bleeding Adverse Effects
Educational Objectives:
At the completion of this activity, participants will be able to:
Outline the efficacy of oral BTK inhibitors across B-cell malignancies including a focus on emerging clinical data
Recognize pharmacists’ responsibilities for monitoring and managing cardiac adverse effects specific to different health-system practice types
Anthony J. Perissinotti, PharmD, BCOP is a Clinical Pharmacist Specialist, Hematology and the Clinical Team Leader Hematology/Oncology as well as an Adjunct Clinical Assistant Professor at the University of Michigan - Michigan Medicine in Ann Arbor, Michigan
He has no relevant financial relationships with commercial interests to disclose.
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours of knowledge-based credit.
Click here to view the activity on the PTCE website and claim your credit: https://www.pharmacytimes.org/on-demand/bcell-malignancies-podcast-part1
This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc and Beigene.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Continuous Glucose Monitors in Diabetes Management | PTCE Pharmacy Connect

Continuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management  
Objectives 
Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations
Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data
Faculty Disclosures
Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Bayer
Speaker’s Bureau: Eli Lilly, NovoNordisk
Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose:
Speaker’s Bureau: Novo Nordisk, Inc.
Other Support: Advanced Practitioner Advisory Board- Novo Nordisk, Inc.
PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for .5 contact hours of knowledge-based credit.
This activity is supported by an independent educational grant from Abbott Diabetes Care Inc.
Learn more here: https://www.pharmacytimes.org/on-demand/continuous-glucose-monitoring-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-in-diabetes-management
Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

PCSK9 Inhibitors | Pharmacy Connect Podcast

Pharmacy Connect Podcast: PCSK9 Inhibitors
Title: PCSK9 Inhibitors:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes With Hyperlipidemia Management 
Special guest: Joseph Saseen, PharmD
Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy 
      Skaggs School of Pharmacy and Pharmaceutical Sciences
      University of Colorado Anschutz Medical Campus
Objectives
Understand the role of PCSK9 inhibitors in the American Heart Association and the American College of Cardiology hyperlipidemia management guidelines
Review the pertinent drug information and clinical benefits of the use of PCSK9 inhibitors in the treatment of hyperlipidemia.
Describe the role of the pharmacist in patient education and counseling on PCSK9 inhibitors for the treatment of hyperlipidemia through motivational interviewing.
CE LINK HERE:
https://www.pharmacytimes.org/on-demand/pcsk9-inhibitors-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-with-hyperlipidemia-management 
PTCE - Pharmacy Times Continuing Education 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices